192 related articles for article (PubMed ID: 24294637)
1. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
[TBL] [Abstract][Full Text] [Related]
2. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
3. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
[TBL] [Abstract][Full Text] [Related]
4. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
[TBL] [Abstract][Full Text] [Related]
5. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
[TBL] [Abstract][Full Text] [Related]
6. Schedules of controlled substances: removal of naloxegol from control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
[TBL] [Abstract][Full Text] [Related]
7. Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 May; 81(91):29142-5. PubMed ID: 27192731
[TBL] [Abstract][Full Text] [Related]
8. Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Oct; 82(198):47971-4. PubMed ID: 29035496
[TBL] [Abstract][Full Text] [Related]
9. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
[TBL] [Abstract][Full Text] [Related]
10. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
[TBL] [Abstract][Full Text] [Related]
11. Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Dec; 76(241):77895-99. PubMed ID: 22175093
[TBL] [Abstract][Full Text] [Related]
12. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
[TBL] [Abstract][Full Text] [Related]
13. Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Sep; 80(176):54715-8. PubMed ID: 26364325
[TBL] [Abstract][Full Text] [Related]
14. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
[TBL] [Abstract][Full Text] [Related]
15. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice.
Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
[TBL] [Abstract][Full Text] [Related]
16. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
Drug Enforcement Administration. Department of Justice
Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
[TBL] [Abstract][Full Text] [Related]
17. Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Jun; 82(108):26349-51. PubMed ID: 28591974
[TBL] [Abstract][Full Text] [Related]
18. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
[TBL] [Abstract][Full Text] [Related]
19. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
[TBL] [Abstract][Full Text] [Related]
20. Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Mar; 79(45):12938-43. PubMed ID: 24611212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
